# BUMETANIDE
> **ANDA212931** · Abbreviated New Drug Application (Generic) · Sponsor: APPCO · Approved 2024-09-18
## Drug
- **FDA Application Number:** ANDA212931
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUMETANIDE
- **Generic name:** BUMETANIDE
- **Active ingredients:** BUMETANIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** APPCO
- **Manufacturer:** Exelan Pharmaceuticals, Inc.
- **First approval:** 2024-09-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212931)
---
*AI Analytics · CC0 1.0*